Founder of Cross BioStrategies biotech consulting firm. Focus on regulatory affairs and clinical development.
20 years experience @FDA, @Genentech, @FortySeven, @Halozyme. Breakthrough therapy programs, INDs, BLAs, in oncology, metabolic, and neurodegenerative diseases.
Board member of Merola Opera Program. Traveller, runner, gardener and novice beekeeper.
Invited by: Amii Barnard-Bahn
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
March 23, 2024 | 34 | 0 | 0.0% |
June 18, 2023 | 34 | 0 | 0.0% |
December 10, 2021 | 34 | +1 | +3.1% |
November 01, 2021 | 33 | +1 | +3.2% |